AGIO · Agios Pharmaceuticals, Inc. · Off Exchange
$38.03
+1.18 (+3.20%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.27B
Shares
59.70M
Volume · Oct 27
739.1K
Avg daily vol (3M)
1.09M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-09-21 | 2,040,274 | 995,014 | 3,035,288 | 55.8% |
| 2026-09-14 | 991,691 | 1,383,744 | 2,375,435 | 42.9% |
| 2026-09-07 | 1,026,993 | 333,539 | 1,360,532 | 41.1% |
| 2026-08-31 | 663,482 | 1,081,008 | 1,744,490 | 45.9% |
| 2026-08-24 | 1,000,242 | 737,887 | 1,738,129 | 46.8% |
| 2026-08-17 | 1,115,876 | 1,333,951 | 2,449,827 | 47.8% |
| 2026-08-10 | 1,491,653 | 953,484 | 2,445,137 | 46.2% |
| 2026-08-03 | 1,624,928 | 819,369 | 2,444,297 | 42.4% |
| 2026-07-27 | 3,154,383 | 517,661 | 3,672,044 | 44.7% |
| 2026-07-20 | 2,028,516 | 622,242 | 2,650,758 | 40.1% |
| 2026-07-13 | 1,022,009 | 206,821 | 1,228,830 | 35.0% |
| 2026-07-06 | 2,115,412 | 850,422 | 2,965,834 | 45.5% |
| 2026-06-29 | 942,055 | 251,545 | 1,193,600 | 32.4% |
| 2026-06-22 | 1,249,615 | 1,254,965 | 2,504,580 | 32.3% |
| 2026-06-15 | 1,148,990 | 820,662 | 1,969,652 | 35.2% |
| 2026-06-08 | 2,239,571 | 487,131 | 2,726,702 | 44.2% |
| 2026-06-01 | 1,197,628 | 435,722 | 1,633,350 | 42.5% |
| 2026-05-25 | 1,324,667 | 493,126 | 1,817,793 | 42.7% |
| 2026-05-18 | 894,299 | 353,334 | 1,247,633 | 35.9% |
| 2026-05-11 | 912,952 | 488,668 | 1,401,620 | 39.0% |
| 2026-05-04 | 1,435,637 | 529,951 | 1,965,588 | 40.6% |
| 2026-04-27 | 2,464,118 | 907,848 | 3,371,966 | 46.6% |
| 2026-04-20 | 3,305,055 | 1,769,129 | 5,074,184 | 46.0% |
| 2026-04-13 | 1,076,020 | 272,431 | 1,348,451 | 39.4% |
| 2026-04-06 | 1,506,030 | 1,037,778 | 2,543,808 | 46.9% |
| 2026-03-30 | 2,045,375 | 902,390 | 2,947,765 | 39.8% |
| 2026-03-23 | 1,118,260 | 504,535 | 1,622,795 | 38.2% |
| 2026-03-16 | 750,888 | 579,439 | 1,330,327 | 33.7% |
| 2026-03-09 | 681,502 | 196,398 | 877,900 | 32.4% |
| 2026-03-02 | 1,471,219 | 466,277 | 1,937,496 | 39.4% |
| 2026-02-23 | 1,355,493 | 319,267 | 1,674,760 | 38.7% |
| 2026-02-16 | 732,700 | 347,394 | 1,080,094 | 35.0% |
| 2026-02-09 | 1,090,511 | 451,307 | 1,541,818 | 38.4% |
| 2026-02-02 | 1,112,266 | 752,722 | 1,864,988 | 37.7% |
| 2026-01-26 | 1,519,625 | 619,786 | 2,139,411 | 46.3% |
| 2026-01-19 | 814,227 | 687,243 | 1,501,470 | 39.3% |
| 2026-01-12 | 1,242,922 | 280,695 | 1,523,617 | 37.0% |
| 2026-01-05 | 1,477,304 | 594,981 | 2,072,285 | 37.3% |
| 2025-12-29 | 1,107,746 | 442,196 | 1,549,942 | 40.6% |
| 2025-12-22 | 2,905,811 | 2,790,169 | 5,695,980 | 49.5% |
| 2025-12-15 | 1,382,084 | 1,587,994 | 2,970,078 | 34.6% |
| 2025-12-08 | 1,559,076 | 1,494,754 | 3,053,830 | 47.4% |
| 2025-12-01 | 1,666,030 | 924,884 | 2,590,914 | 39.8% |
| 2025-11-24 | 1,856,704 | 1,951,695 | 3,808,399 | 42.7% |
| 2025-11-17 | 8,318,187 | 6,024,117 | 14,342,304 | 47.2% |
| 2025-11-10 | 1,266,923 | 383,406 | 1,650,329 | 48.7% |
| 2025-11-03 | 870,182 | 320,407 | 1,190,589 | 42.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1439222
CUSIP
00847X104
13F (30d)
35 filings
35 filers
Visit website
Investor relations